The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors
Abstract
Direct in situ introduction of exogenous genes into proliferating tumors could provide an effective therapeutic approach for treatment of localized tumors. Rats with a cerebral glioma were given an intratumoral stereotaxic injection of murine fibroblasts that were producing a retroviral vector in which the herpes simplex thymidine kinase (HS-tk) gene had been inserted. After 5 days during which the HS-tk retroviral vectors that were produced in situ transduced the neighboring proliferating glioma cells, the rats were treated with the anti-herpes drug ganciclovir. Gliomas in the ganciclovir- and vector-treated rats regressed completely both macroscopically and microscopically. This technique exploits what was previously considered to be a disadvantage of retroviral vectors—that is, their inability to transfer genes into nondividing cells. Instead, this feature of retroviruses is used to target gene delivery to dividing tumor cells and to spare nondividing neural tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,971
Moolten, F. L. (1986) · PubMed · Cited by 972
Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916
Miller, D. G., Adam, M. A., & Miller, A. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4239 · Cited by 893
Murine interleukin-4 displays potent anti-tumor activity in vivo
Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 778
Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral Vectors
Moolten, F. L., & Wells, J. M. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.4.297 · Cited by 507
Mullen, C. A., Kilstrup, M., & Blaese, R. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.33 · Cited by 497
Self-citationGänsbacher, B., Bannerji, R., Daniels, B. F., Zier, K. S., Cronin, K. A., & Gilboa, E. (1990) · PubMed · Cited by 414
Widner, H., & Brundin, P. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90010-0 · Cited by 287
In Vivo Antitumor Activity of Tumor-Infiltrating Lymphocytes Expanded in Recombinant Interleukin-2
(1987) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/79.5.1067 · Cited by 258
Cited by
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Self-citationPax6 Controls Progenitor Cell Identity and Neuronal Fate in Response to Graded Shh Signaling
Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van Heyningen, V, Jessell, T. M., & Briscoe, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80323-2 · Cited by 1,043
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905
“Because HsvTK metabolizes ganciclovir (GCV) into a toxic agent specifically in cells expressing HsvTK (Culver et al., 1992), G-pericytes expressing HsvTK should be sensitive to GCV and thus eliminated by GCV treatment .”
Glioblastoma multiforme: The terminator
Holland, E. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6242 · Cited by 762
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732
Rainov, N. G. (2000) · Human Gene Therapy · doi:10.1089/104303400750038499 · Cited by 698
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1354 · Cited by 668
Self-citationGene Therapy for Cancer: What Have We Done and Where Are We Going?
Roth, J. A., & Cristiano, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.21 · Cited by 635
Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., & Demeneix, B. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-1947 · Cited by 541
Transfer of a foreign gene into the brain using adenovirus vectors
Akli, S., Caillaud, C., Vigne, E., Stratford-Perricaudet, L. D., Poenaru, L., Perricaudet, M., Kahn, A., & Peschanski, M. R. (1993) · Nature Genetics · doi:10.1038/ng0393-224 · Cited by 532
Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, R. G., & Woo, S. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3054 · Cited by 478
Generation of purified neural precursors from embryonic stem cells by lineage selection
Li, M., Pevny, L., Lovell-Badge, R., & Smith, A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70399-9 · Cited by 461
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
Ohno, T., Gordon, D., San, H., Pompili, V. J., Imperiale, M. J., Nabel, G. J., & Nabel, E. G. (1994) · Science · doi:10.1126/science.8047883 · Cited by 433
Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., & Good, S. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8302 · Cited by 420
Li Bi, W., Parysek, L. M., Warnick, R., & Stambrook, P. J. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-725 · Cited by 416
Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., & Yamasaki, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1831 · Cited by 411
Immonen, A., Vapalahti, M., Tyynelä, K., Hurskainen, H., Sandmair, A., Vanninen, R., Langford, G., Murray, N., & Ylä-Herttuala, S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.002 · Cited by 390
Bajocchi, G., Feldman, S. H., Crystal, R. G., & Mastrangeli, A. (1993) · Nature Genetics · doi:10.1038/ng0393-229 · Cited by 378
Improved Methods of Retroviral Vector Transduction and Production for Gene Therapy
Kotani, H., Newton, P. B., Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F., & McGarrity, G. J. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.1-19 · Cited by 370
Self-citationIntergeneric poliovirus recombinants for the treatment of malignant glioma
Gromeier, M., Lachmann, S., Rosenfeld, M. R., Gutin, P. H., & Wimmer, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6803 · Cited by 363
Imaging Transgene Expression with Radionuclide Imaging Technologies
Gambhir, S. S., Herschman, H. R., Cherry, S. R., Barrio, J. R., Satyamurthy, N., Toyokuni, T., Phelps, M. E., Larson, S. M., Balatoni, J., Finn, R., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900083 · Cited by 358
Barth, R. F. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005805203044 · Cited by 353
Sterman, D. H., Treat, J., Litzky, L. A., Amin, K. M., Coonrod, L., Molnar-Kimber, K., Recio, A., Knox, L., Wilson, J. M., Albelda, S. M., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.7-1083 · Cited by 341
Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., & Sobol, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2909 · Cited by 334
Trojan, J., Johnson, T. R., Rudin, S. D., Ilan, J., Tykocinski, M. L., & Ilan, J. (1993) · Science · doi:10.1126/science.8418502 · Cited by 329
Viral gene therapy strategies: from basic science to clinical application
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006) · The Journal of Pathology · doi:10.1002/path.1896 · Cited by 313
Dewey, R. A., Morrissey, G., Cowsill, C. M., Stone, D., Bolognani, F., Dodd, N. J. F., Southgate, T. D., Klatzmann, D., Lassmann, H., Castro, M. G., et al. (1999) · Nature Medicine · doi:10.1038/15207 · Cited by 311
Sandmair, A.-M., Loimas, S., Puranen, P., Immonen, A., Kossila, M., Puranen, M., Hurskainen, H., Tyynelä, K., Turunen, M., Vanninen, R., et al. (2000) · Human Gene Therapy · doi:10.1089/104303400750035726 · Cited by 300
Barba, D., Hardin, J., Sadelain, M., & Gage, F. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4348 · Cited by 297
Hallenbeck, P. L., Chang, Y.-N., Hay, C., Golightly, D., Stewart, D., Lin, J., Phipps, S., & Chiang, Y. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950017725 · Cited by 283
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Targeted prodrug design to optimize drug delivery
Han, H.-K., & Amidon, G. L. (2000) · AAPS PharmSci · doi:10.1208/ps020106 · Cited by 277
Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
Black, M. E., Newcomb, T. G., Wilson, H. M., & Loeb, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3525 · Cited by 275
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
Greco, O., & Dachs, G. U. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(2001)9999:9999<::aid-jcp1060>3.0.co;2-h · Cited by 273
A brief history of gene therapy
Friedmann, T. (1992) · Nature Genetics · doi:10.1038/ng1092-93 · Cited by 273
Klatzmann, D., Valery, C. A., Bensimon, G., Marro, B., Boyer, O., Mokhtari, K., Diquet, B., Salzmann, J.-L., Philippon, J., & Glioblastoma, S. G. O. G. T. F. (1998) · Human Gene Therapy · doi:10.1089/10430349850019436 · Cited by 269
Lasic, D. D., & Templeton, N. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00002-6 · Cited by 261
Smith, A. E. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.004111 · Cited by 258
Lipid nanoparticle-mediated drug delivery to the brain
Khare, P., Edgecomb, S. X., Hamadani, C. M., Tanner, E. E. L., & S Manickam, D. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114861 · Cited by 187
Meta-analysis. Beyond the grand mean?
Smith, G. D., Egger, M., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7122.1610 · Cited by 174
Connexins: Key Mediators of Endocrine Function
Bosco, D., Haefliger, J.-A., & Meda, P. (2011) · Physiological Reviews · doi:10.1152/physrev.00027.2010 · Cited by 169
Beltinger, C., Fulda, S., Kammertoens, T., Meyer, E., Uckert, W., & Debatin, K.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8699 · Cited by 143
Molecular mechanism of retroviral DNA integration
Kulkosky, J., & Skalka, A. M. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90062-0 · Cited by 56
de Oliveira, A. P., & Fraefel, C. (2010) · The Open Virology Journal · doi:10.2174/1874357901004030109 · Cited by 3
Metadata
- Authors
- Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M.
- Venue
- Science
- Published
- 1992-06-12
- Volume
- 256
- Issue
- 5063
- Pages
- 1550-1552
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016138321
- Cited by
- 1,509
- References
- 13
- FWCI
- 67.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.